Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program

BACKGROUND: There are clinical situations (CS) in which the use of somatostatin analogs (SSAs) in patients with neuroendocrine tumors (NET) is controversial due to lack of evidence. A Delphi study was conducted to develop common treatment guidelines for these CS, based on clinical practice and exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevilla, Isabel, Segura, Ángel, Capdevila, Jaume, López, Carlos, García-Carbonero, Rocío, Grande, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100262/
https://www.ncbi.nlm.nih.gov/pubmed/27821081
http://dx.doi.org/10.1186/s12885-016-2901-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100262/
https://www.ncbi.nlm.nih.gov/pubmed/27821081
http://dx.doi.org/10.1186/s12885-016-2901-1

Ejemplares similares